Two mugs of tea, a paper calendar and a small bunch of wildflowers on a kitchen table

GLP-1 treatment, contraception and planning a pregnancy: what to know

In short

GLP-1 medicines for weight management are not intended for use in pregnancy or breastfeeding. If you want to become pregnant, they're stopped beforehand, with a time gap stated in the product information. Exactly when they are stopped is decided by the medical review in each individual case.

At the same time, weight loss can change fertility, and with some medicines the pill may be less reliable in certain phases. So contraception deserves particular attention during treatment.

Fertility: what's behind the rumours

Social media carries stories of unexpected pregnancies during GLP-1 treatment. A plausible explanation: excess weight can disrupt ovulation, for example with PCOS. As weight falls, cycles may normalise and fertility can rise.

It's not an effect to rely on in either direction, and robust data are still scarce.

Does the pill still work?

Vomiting and severe diarrhoea can affect how well the pill is absorbed, whatever the treatment. That matters especially during titration, when gut complaints are more common.

For tirzepatide, the product information also states that the effect of oral contraceptives may be reduced in certain phases of treatment and recommends an additional or different method then. Ask your gynaecologist which method suits you during treatment. Whether and how a switch or a dose change happens is decided by the doctor in each individual case.

Planning a pregnancy, pregnancy and breastfeeding

If you want to become pregnant, say so openly when treatment is prescribed. Treatment is then stopped beforehand. How long before depends on the medicine and is in the product information.

If you become pregnant during treatment, stop the medicine and contact a doctor promptly. GLP-1 medicines for weight management are also not used while breastfeeding.

Note

This Journal article offers general information. It is not a diagnosis, a prescription or a promise of any result. Whether treatment is suitable for you is decided by a doctor after reviewing your questionnaire. For acute or severe symptoms, contact your GP, the out-of-hours medical service (116117) or, in an emergency, 112. Whether and how a switch or a dose change happens is decided by the doctor in each individual case.

Sources and medical review

Based on European Medicines Agency product information for semaglutide, tirzepatide and liraglutide. Educational only; does not replace a gynaecological examination. Medical review pending.

  • European Medicines Agency product information for semaglutide, tirzepatide and liraglutide (fertility, pregnancy and lactation; interactions)